Skip to main content
Y-Biologics, Inc logo

Y-Biologics, Inc — Investor Relations & Filings

Ticker · 338840 ISIN · KR7338840002 KO Professional, scientific and technical activities
Open in API
Filings indexed 117 across all filing types
Latest filing 2025-03-21 Annual Report
Country KR South Korea
Listing KO 338840

About Y-Biologics, Inc

https://ybiologics.com/en/

Y-Biologics, Inc. is a biotechnology company specializing in the discovery and development of novel antibody-based therapeutics. The company's primary focus is on immuno-oncology, where it develops next-generation multispecific antibodies for the treatment of cancer. Y-Biologics leverages its proprietary human antibody discovery platform to advance its internal pipeline and support collaborations through technology transfers and joint development partnerships.

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the 17th fiscal year (2024) of Y-Biologics Inc. It contains comprehensive financial data, business operations, management information, and capital structure details. In the context of Korean corporate filings, the '사업보고서' is the equivalent of the annual comprehensive financial report, which corresponds to the 10-K filing type. FY 2024
2025-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Y-Biologics. It contains the meeting agenda, details on voting procedures, and management information (such as director activities and financial statements). This type of document is standard for providing shareholders with the necessary information to vote on company matters at an AGM, which falls under the Proxy Solicitation & Information Statement category.
2025-03-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. It is a short announcement (832 characters) notifying the market of the event rather than the presentation materials themselves. Under the 'Menu vs Meal' rule, this is classified as a Regulatory Filing (RNS) as it is a standard corporate disclosure of an event schedule.
2025-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Y-Biologics regarding a significant change (over 30%) in revenue or profit/loss structure. This is a standard financial disclosure required by the Korea Exchange (KRX) when a company's financial performance deviates significantly from the previous period. It provides key financial highlights (revenue, operating profit, net income) and the reasons for the change. Since this is an initial announcement of financial results rather than a full annual report or a simple report publication notice, it falls under the 'Earnings Release' category. FY 2024
2025-02-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Y-Biologics. It outlines the date, location, and agenda items for the upcoming Annual General Meeting (AGM), including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and meeting notice provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2025-02-13 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the record date for shareholder rights. Given the nature of the announcement as a regulatory disclosure regarding meeting preparation, it fits best under the RNS (Regulatory Filings) category as it is a standard corporate notification.
2024-12-16 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.